Biospecimen Catalog
Filter by disease, sample type, clinical history, and more. Not finding what you need? Request a custom collection
| Primary diagnosis is EHR-verified. Comorbidities are donor-reported; EHR-verified comorbidity data is available on request. | Sample Type | Bag Size | Cells / Volume | Additive Type | Primary Disease | Diagnosis | Allergies | Allergy List | Has Food Allergies | BMI | CMV Status | HIV/HBV/HCV Tested | Syphilis Tested | Tobacco Use | Years of Smoking | Packs per Day | Alcohol Use | Recreational Drug Use | Caffeine Use | ABO Type | Rh Type | Viable CD45+ (% of singlets) | CD3+ T cells (% of viable CD45+) | CD4+CD8− (% of viable CD45+) | CD4−CD8+ (% of viable CD45+) | CD3−CD16/56+ NK (% of viable CD45+) | CD19+ B cells (% of viable CD45+) | CD14+ monocytes (% of viable CD45+) | Sample Status | Availability | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Healthy Serum | 82673 | 156162 | Female | 46-60 | Caucasian | Frozen | 1 mL | 4 | — | Losartan 160mg amlodipine 5mg | — | United States | 2026 | 02:01:01G | 44:02:01G/51:01:01G | 05:01:01G/14:02:01G | 04:01:01G/08:01:01G | 01:01:01G | 03:01:01G/04:01:01G | 03:01:01G/04:02:01G | 01:03:01G | 04:01:01G/20:01:01G | Serum | 1.0 ML | SST | Normal (Healthy) | Healthy | Yes | Codeine | 41.19 | Non Reactive | Yes | No | No | No | NO | Yes | A | RH+ | Stored | In Stock |
$132 / vial
4 vials left
|
|||||||||||
| Healthy PBMC | 58417 | 139255 | Male | 31-45 | Caucasian | Cryopreserved | 1 mL | 48 | 100M | Bupropion XL 300mg qd. Takes Men's multivitamin | — | United States | 2026 | 02:01:01:01/02:05:01:01 | — | — | — | — | — | — | — | — | PBMC | 100M cells | ACD | Normal (Healthy) | Healthy | No | 22.31 | Non Reactive | Yes | No | No | Yes | NO | Yes | O | RH+ | Stored | In Stock |
$578 / vial
48 vials left
|
||||||||||||
| Healthy PBMC | 82647 | 23470 | Female | 61+ | Caucasian | Cryopreserved | 1 mL | 5 | 10M | lisinopril 20mg QD Restasis 1 drop into both eyes BID Lexapro 20mg QD | — | United States | 2026 | 02:01:01G/03:01:01G | 07:02:01G/57:01:01G | 06:02:01G/07:02:01G | 04:07:01G/07:01:01G | 01:01:01G | 02:01:01G/03:01:01G | 03:01:01G/03:03:02G | 01:03:01G | 04:01:01G | PBMC | 10M cells | EDTA | Normal (Healthy) | Healthy | No | 23.57 | Non Reactive | Yes | No | No | No | NO | Yes | A | RH+ | Stored | In Stock |
$205 / vial
5 vials left
|
||||||||||||
| Myasthenia Gravis PBMC | 82582 | 110012 | Female | 31-45 | Caucasian | Cryopreserved | 1 mL | 6 | 10M | **IV bard power port needle 3/4ths** Vvygart Infusion, weekly on Mondays x4 revaluating Tylenol (with IVIG and Soliris) Benadryl (with IVIG) IV Benadryl (with Soliris) *Amitriptyline 10 mg: 4 at night *Calcium 600 mg plus D3 20 mcg: 1 in morning *Folic acid: 1mg tablets *B12 1000 mcg: 1 in morning -Continuous Meds- *Testosterone CYP 120 mg/ .6 ml subcutaneous: once every Wednesday *Lamictal 200 mg ER: 1 in morning, 1 at night *Ritalin 20 mg: 1 pill morning, 1 pill noon *buspar 10 mg: 1 pill morning, 1 pill noon, 1 pill at night *Lexapro 20 mg: 1 in morning *Seroquel 100 mg er: 3 at night -As Needed Meds- *Lorazepam 1 mg: as needed *Hydroxyzine: as needed Amlodipine tab 10mg: 1 in morning *Topamax 50 mg: 1 in morning, 1 at night *Ropinirole HCL 3 mg: 1 at night *BIPAP: Pressure 18 over 13 *Famotidine 20 mg: 1 in morning, 1 at night --As Needed Meds-- *Ondansetron ODT 4 mg: as needed *Finacea (azealic acid) *Ventolin HFA 90 mcg per actuation: as needed *Trimodal 50mg: as needed *Triamcinolone Acetonide ointment USP, 0.1%: as needed | Rosacea, Hidradenitis Suppurativa, Myasthenia Gravis | United States | 2026 | — | — | — | — | — | — | — | — | — | PBMC | 10M cells | EDTA | Myasthenia Gravis | Myasthenia Gravis;Rosacea;Hidradenitis Suppurativa | Yes | bactrim, monoset, nasonex | 37.93 | No | No | No | No | NO | No | Stored | In Stock |
$765 / vial
6 vials left
|
||||||||||||||
| Myasthenia Gravis Plasma | 73627 | 110012 | Female | 31-45 | Caucasian | Frozen | 1 mL | 17 | — | **IV bard power port needle 3/4ths** Vvygart Infusion, weekly on Mondays x4 revaluating Tylenol (with IVIG and Soliris) Benadryl (with IVIG) IV Benadryl (with Soliris) *Amitriptyline 10 mg: 4 at night *Calcium 600 mg plus D3 20 mcg: 1 in morning *Folic acid: 1mg tablets *B12 1000 mcg: 1 in morning -Continuous Meds- *Testosterone CYP 120 mg/ .6 ml subcutaneous: once every Wednesday *Lamictal 200 mg ER: 1 in morning, 1 at night *Ritalin 20 mg: 1 pill morning, 1 pill noon *buspar 10 mg: 1 pill morning, 1 pill noon, 1 pill at night *Lexapro 20 mg: 1 in morning *Seroquel 100 mg er: 3 at night -As Needed Meds- *Lorazepam 1 mg: as needed *Hydroxyzine: as needed Amlodipine tab 10mg: 1 in morning *Topamax 50 mg: 1 in morning, 1 at night *Ropinirole HCL 3 mg: 1 at night *BIPAP: Pressure 18 over 13 *Famotidine 20 mg: 1 in morning, 1 at night --As Needed Meds-- *Ondansetron ODT 4 mg: as needed *Finacea (azealic acid) *Ventolin HFA 90 mcg per actuation: as needed *Trimodal 50mg: as needed *Triamcinolone Acetonide ointment USP, 0.1%: as needed | Myasthenia Gravis | United States | 2026 | — | — | — | — | — | — | — | — | — | Plasma | 1.0 ML | EDTA | Myasthenia Gravis | Myasthenia Gravis | Yes | bactrim, monoset, nasonex | 37.93 | No | No | No | No | NO | No | Stored | In Stock |
$495 / vial
17 vials left
|
||||||||||||||
| Myasthenia Gravis Serum | 73627 | 110012 | Female | 31-45 | Caucasian | Frozen | 1 mL | 4 | — | **IV bard power port needle 3/4ths** Vvygart Infusion, weekly on Mondays x4 revaluating Tylenol (with IVIG and Soliris) Benadryl (with IVIG) IV Benadryl (with Soliris) *Amitriptyline 10 mg: 4 at night *Calcium 600 mg plus D3 20 mcg: 1 in morning *Folic acid: 1mg tablets *B12 1000 mcg: 1 in morning -Continuous Meds- *Testosterone CYP 120 mg/ .6 ml subcutaneous: once every Wednesday *Lamictal 200 mg ER: 1 in morning, 1 at night *Ritalin 20 mg: 1 pill morning, 1 pill noon *buspar 10 mg: 1 pill morning, 1 pill noon, 1 pill at night *Lexapro 20 mg: 1 in morning *Seroquel 100 mg er: 3 at night -As Needed Meds- *Lorazepam 1 mg: as needed *Hydroxyzine: as needed Amlodipine tab 10mg: 1 in morning *Topamax 50 mg: 1 in morning, 1 at night *Ropinirole HCL 3 mg: 1 at night *BIPAP: Pressure 18 over 13 *Famotidine 20 mg: 1 in morning, 1 at night --As Needed Meds-- *Ondansetron ODT 4 mg: as needed *Finacea (azealic acid) *Ventolin HFA 90 mcg per actuation: as needed *Trimodal 50mg: as needed *Triamcinolone Acetonide ointment USP, 0.1%: as needed | Myasthenia Gravis | United States | 2026 | — | — | — | — | — | — | — | — | — | Serum | 1.0 ML | SST | Myasthenia Gravis | Myasthenia Gravis | Yes | bactrim, monoset, nasonex | 37.93 | No | No | No | No | NO | No | Stored | In Stock |
$495 / vial
4 vials left
|
||||||||||||||
| Myasthenia Gravis PBMC | 73627 | 110012 | Female | 31-45 | Caucasian | Cryopreserved | 1 mL | 6 | 10M | **IV bard power port needle 3/4ths** Vvygart Infusion, weekly on Mondays x4 revaluating Tylenol (with IVIG and Soliris) Benadryl (with IVIG) IV Benadryl (with Soliris) *Amitriptyline 10 mg: 4 at night *Calcium 600 mg plus D3 20 mcg: 1 in morning *Folic acid: 1mg tablets *B12 1000 mcg: 1 in morning -Continuous Meds- *Testosterone CYP 120 mg/ .6 ml subcutaneous: once every Wednesday *Lamictal 200 mg ER: 1 in morning, 1 at night *Ritalin 20 mg: 1 pill morning, 1 pill noon *buspar 10 mg: 1 pill morning, 1 pill noon, 1 pill at night *Lexapro 20 mg: 1 in morning *Seroquel 100 mg er: 3 at night -As Needed Meds- *Lorazepam 1 mg: as needed *Hydroxyzine: as needed Amlodipine tab 10mg: 1 in morning *Topamax 50 mg: 1 in morning, 1 at night *Ropinirole HCL 3 mg: 1 at night *BIPAP: Pressure 18 over 13 *Famotidine 20 mg: 1 in morning, 1 at night --As Needed Meds-- *Ondansetron ODT 4 mg: as needed *Finacea (azealic acid) *Ventolin HFA 90 mcg per actuation: as needed *Trimodal 50mg: as needed *Triamcinolone Acetonide ointment USP, 0.1%: as needed | Myasthenia Gravis | United States | 2026 | — | — | — | — | — | — | — | — | — | PBMC | 10M cells | EDTA | Myasthenia Gravis | Myasthenia Gravis | Yes | bactrim, monoset, nasonex | 37.93 | No | No | No | No | NO | No | Stored | In Stock |
$765 / vial
6 vials left
|
||||||||||||||
| Myasthenia Gravis Plasma | 77426 | 110012 | Female | 31-45 | Caucasian | Frozen | 1 mL | 16 | — | **IV bard power port needle 3/4ths** Vvygart Infusion, weekly on Mondays x4 revaluating Tylenol (with IVIG and Soliris) Benadryl (with IVIG) IV Benadryl (with Soliris) *Amitriptyline 10 mg: 4 at night *Calcium 600 mg plus D3 20 mcg: 1 in morning *Folic acid: 1mg tablets *B12 1000 mcg: 1 in morning -Continuous Meds- *Testosterone CYP 120 mg/ .6 ml subcutaneous: once every Wednesday *Lamictal 200 mg ER: 1 in morning, 1 at night *Ritalin 20 mg: 1 pill morning, 1 pill noon *buspar 10 mg: 1 pill morning, 1 pill noon, 1 pill at night *Lexapro 20 mg: 1 in morning *Seroquel 100 mg er: 3 at night -As Needed Meds- *Lorazepam 1 mg: as needed *Hydroxyzine: as needed Amlodipine tab 10mg: 1 in morning *Topamax 50 mg: 1 in morning, 1 at night *Ropinirole HCL 3 mg: 1 at night *BIPAP: Pressure 18 over 13 *Famotidine 20 mg: 1 in morning, 1 at night --As Needed Meds-- *Ondansetron ODT 4 mg: as needed *Finacea (azealic acid) *Ventolin HFA 90 mcg per actuation: as needed *Trimodal 50mg: as needed *Triamcinolone Acetonide ointment USP, 0.1%: as needed | Hidradenitis Suppurativa, Myasthenia Gravis | United States | 2026 | — | — | — | — | — | — | — | — | — | Plasma | 1.0 ML | EDTA | Myasthenia Gravis | Myasthenia Gravis;Hidradenitis Suppurativa | Yes | bactrim, monoset, nasonex | 37.93 | No | No | No | No | NO | No | Stored | In Stock |
$495 / vial
16 vials left
|
||||||||||||||
| Myasthenia Gravis Serum | 77426 | 110012 | Female | 31-45 | Caucasian | Frozen | 1 mL | 8 | — | **IV bard power port needle 3/4ths** Vvygart Infusion, weekly on Mondays x4 revaluating Tylenol (with IVIG and Soliris) Benadryl (with IVIG) IV Benadryl (with Soliris) *Amitriptyline 10 mg: 4 at night *Calcium 600 mg plus D3 20 mcg: 1 in morning *Folic acid: 1mg tablets *B12 1000 mcg: 1 in morning -Continuous Meds- *Testosterone CYP 120 mg/ .6 ml subcutaneous: once every Wednesday *Lamictal 200 mg ER: 1 in morning, 1 at night *Ritalin 20 mg: 1 pill morning, 1 pill noon *buspar 10 mg: 1 pill morning, 1 pill noon, 1 pill at night *Lexapro 20 mg: 1 in morning *Seroquel 100 mg er: 3 at night -As Needed Meds- *Lorazepam 1 mg: as needed *Hydroxyzine: as needed Amlodipine tab 10mg: 1 in morning *Topamax 50 mg: 1 in morning, 1 at night *Ropinirole HCL 3 mg: 1 at night *BIPAP: Pressure 18 over 13 *Famotidine 20 mg: 1 in morning, 1 at night --As Needed Meds-- *Ondansetron ODT 4 mg: as needed *Finacea (azealic acid) *Ventolin HFA 90 mcg per actuation: as needed *Trimodal 50mg: as needed *Triamcinolone Acetonide ointment USP, 0.1%: as needed | Hidradenitis Suppurativa, Myasthenia Gravis | United States | 2026 | — | — | — | — | — | — | — | — | — | Serum | 1.0 ML | SST | Myasthenia Gravis | Myasthenia Gravis;Hidradenitis Suppurativa | Yes | bactrim, monoset, nasonex | 37.93 | No | No | No | No | NO | No | Stored | In Stock |
$495 / vial
8 vials left
|
||||||||||||||
| Myasthenia Gravis PBMC | 77426 | 110012 | Female | 31-45 | Caucasian | Cryopreserved | 1 mL | 4 | 10M | **IV bard power port needle 3/4ths** Vvygart Infusion, weekly on Mondays x4 revaluating Tylenol (with IVIG and Soliris) Benadryl (with IVIG) IV Benadryl (with Soliris) *Amitriptyline 10 mg: 4 at night *Calcium 600 mg plus D3 20 mcg: 1 in morning *Folic acid: 1mg tablets *B12 1000 mcg: 1 in morning -Continuous Meds- *Testosterone CYP 120 mg/ .6 ml subcutaneous: once every Wednesday *Lamictal 200 mg ER: 1 in morning, 1 at night *Ritalin 20 mg: 1 pill morning, 1 pill noon *buspar 10 mg: 1 pill morning, 1 pill noon, 1 pill at night *Lexapro 20 mg: 1 in morning *Seroquel 100 mg er: 3 at night -As Needed Meds- *Lorazepam 1 mg: as needed *Hydroxyzine: as needed Amlodipine tab 10mg: 1 in morning *Topamax 50 mg: 1 in morning, 1 at night *Ropinirole HCL 3 mg: 1 at night *BIPAP: Pressure 18 over 13 *Famotidine 20 mg: 1 in morning, 1 at night --As Needed Meds-- *Ondansetron ODT 4 mg: as needed *Finacea (azealic acid) *Ventolin HFA 90 mcg per actuation: as needed *Trimodal 50mg: as needed *Triamcinolone Acetonide ointment USP, 0.1%: as needed | Hidradenitis Suppurativa, Myasthenia Gravis | United States | 2026 | — | — | — | — | — | — | — | — | — | PBMC | 10M cells | EDTA | Myasthenia Gravis | Myasthenia Gravis;Hidradenitis Suppurativa | Yes | bactrim, monoset, nasonex | 37.93 | No | No | No | No | NO | No | Stored | In Stock |
$765 / vial
4 vials left
|
||||||||||||||
| Osteoarthritis PBMC | 82711 | 154650 | Female | 46-60 | African American | Cryopreserved | 1 mL | 5 | 10M | amLODIPine (NORVASC) 10 MG 1xday ghydroCHLOROthiazide 12.5 MG 1xday atorvastatin (LIPITOR) 20 MG 1xday Carvedilol 12.5 MG 1xday | Osteoarthritis | United States | 2026 | — | — | — | — | — | — | — | — | — | PBMC | 10M cells | EDTA | Osteoarthritis | Osteoarthritis | No | 42.43 | No | No | Used to Smoke | 10 | 0.5 | No | NO | Yes | Stored | In Stock |
$530 / vial
5 vials left
|
|||||||||||||
| Diabetes Type II PBMC | 82618 | 123905 | Male | 61+ | Caucasian | Cryopreserved | 1 mL | 27 | 50M | Balsalazide 750mg 3x TID Nitroglycerine Ointment 1.5mg/inch of ointment BID Stelara IV infusion Q8W (last ) Metformin 1000mg BID Glipizide 10mg BID Tamsulosin QD Finasteride QD FARXIGA® (dapagliflozin)/QD | Ulcerative Colitis, Crohn's Disease, Diabetes Type II | United States | 2026 | 03:01:01G/31:01:02G | 35:02:01G/37:01:01G | 04:01:01G/06:02:01G | 04:03:01G/11:04:01G | 01:01:01G | 03:01:01G/05:01:01G | 03:01:01G/03:05:01G | 01:03:01G | 04:01:01G/04:02:01G | PBMC | 50M cells | ACD | Diabetes Type II | Diabetes Type 2;Ulcerative Colitis;Crohn's Disease | Yes | Amoxicillin | 27.8 | Non Reactive | Yes | Yes | No | No | NO | Yes | O | RH+ | Stored | In Stock |
$1,109 / vial
27 vials left
|
|||||||||||
| Diabetes Type II PBMC | 82618 | 123905 | Male | 61+ | Caucasian | Cryopreserved | 1 mL | 12 | 10M | Balsalazide 750mg 3x TID Nitroglycerine Ointment 1.5mg/inch of ointment BID Stelara IV infusion Q8W (last ) Metformin 1000mg BID Glipizide 10mg BID Tamsulosin QD Finasteride QD FARXIGA® (dapagliflozin)/QD | Ulcerative Colitis, Crohn's Disease, Diabetes Type II | United States | 2026 | 03:01:01G/31:01:02G | 35:02:01G/37:01:01G | 04:01:01G/06:02:01G | 04:03:01G/11:04:01G | 01:01:01G | 03:01:01G/05:01:01G | 03:01:01G/03:05:01G | 01:03:01G | 04:01:01G/04:02:01G | PBMC | 10M cells | ACD | Diabetes Type II | Diabetes Type 2;Ulcerative Colitis;Crohn's Disease | Yes | Amoxicillin | 27.8 | Non Reactive | Yes | Yes | No | No | NO | Yes | O | RH+ | Stored | In Stock |
$530 / vial
12 vials left
|
|||||||||||
| Diabetes Type II Serum | 82618 | 123905 | Male | 61+ | Caucasian | Frozen | 1 mL | 6 | — | Balsalazide 750mg 3x TID Nitroglycerine Ointment 1.5mg/inch of ointment BID Stelara IV infusion Q8W (last ) Metformin 1000mg BID Glipizide 10mg BID Tamsulosin QD Finasteride QD FARXIGA® (dapagliflozin)/QD | Ulcerative Colitis, Crohn's Disease, Diabetes Type II | United States | 2026 | 03:01:01G/31:01:02G | 35:02:01G/37:01:01G | 04:01:01G/06:02:01G | 04:03:01G/11:04:01G | 01:01:01G | 03:01:01G/05:01:01G | 03:01:01G/03:05:01G | 01:03:01G | 04:01:01G/04:02:01G | Serum | 1.0 ML | SST | Diabetes Type II | Diabetes Type 2;Ulcerative Colitis;Crohn's Disease | Yes | Amoxicillin | 27.8 | Non Reactive | Yes | Yes | No | No | NO | Yes | O | RH+ | Stored | In Stock |
$316 / vial
6 vials left
|
|||||||||||
| Diabetes Type II Plasma | 82618 | 123905 | Male | 61+ | Caucasian | Frozen | 1 mL | 8 | — | Balsalazide 750mg 3x TID Nitroglycerine Ointment 1.5mg/inch of ointment BID Stelara IV infusion Q8W (last ) Metformin 1000mg BID Glipizide 10mg BID Tamsulosin QD Finasteride QD FARXIGA® (dapagliflozin)/QD | Ulcerative Colitis, Crohn's Disease, Diabetes Type II | United States | 2026 | 03:01:01G/31:01:02G | 35:02:01G/37:01:01G | 04:01:01G/06:02:01G | 04:03:01G/11:04:01G | 01:01:01G | 03:01:01G/05:01:01G | 03:01:01G/03:05:01G | 01:03:01G | 04:01:01G/04:02:01G | Plasma | 1.0 ML | EDTA | Diabetes Type II | Diabetes Type 2;Ulcerative Colitis;Crohn's Disease | Yes | Amoxicillin | 27.8 | Non Reactive | Yes | Yes | No | No | NO | Yes | O | RH+ | Stored | In Stock |
$316 / vial
8 vials left
|
|||||||||||
| Rheumatoid Arthritis PBMC | 80885 | 1557857 | Female | 61+ | Hispanic/Latino | Cryopreserved | 1 mL | 2 | 5M | CTLA-1 Ig therapy (abatacept) | Rheumatoid Arthritis | — | 2026 | — | — | — | — | — | — | — | — | — | PBMC | 5M cells | NAHEP | Rheumatoid Arthritis | Rheumatoid Arthritis | No | 31.61 | No | No | No | No | NO | No | Stored | In Stock |
$530 / vial
2 vials left
|
|||||||||||||||
| Breast Cancer PBMC | 82455 | 157878 | Female | 46-60 | Caucasian | Cryopreserved | 1 mL | 59 | 50M | EMGALITY – MIGRAINE PROPHYLAXIS 70 MG MONTHLY | Breast Cancer | United States | 2026 | 01:01:01G/26:01:01G | 08:01:01G/35:01:01G | 04:01:01G/07:01:01G | 03:01:01G/04:02:01G | 01:01:01G | 03:01:01G/05:01:01G | 02:01:01G/03:02:01G | 01:03:01G/02:01:02G | 01:01:01G/04:01:01G | PBMC | 50M cells | ACD | Breast Cancer | Breast Cancer | No | 23.29 | Non Reactive | No | Yes | No | Yes | NO | Yes | Stored | In Stock |
$1,195 / vial
59 vials left
|
||||||||||||||
| Breast Cancer PBMC | 82455 | 157878 | Female | 46-60 | Caucasian | Cryopreserved | 1 mL | 9 | 10M | EMGALITY – MIGRAINE PROPHYLAXIS 70 MG MONTHLY | Breast Cancer | United States | 2026 | 01:01:01G/26:01:01G | 08:01:01G/35:01:01G | 04:01:01G/07:01:01G | 03:01:01G/04:02:01G | 01:01:01G | 03:01:01G/05:01:01G | 02:01:01G/03:02:01G | 01:03:01G/02:01:02G | 01:01:01G/04:01:01G | PBMC | 10M cells | ACD | Breast Cancer | Breast Cancer | No | 23.29 | Non Reactive | No | Yes | No | Yes | NO | Yes | Stored | In Stock |
$1,195 / vial
9 vials left
|
||||||||||||||
| Atopic Dermatitis (Eczema) PBMC | 82520 | 138119 | Female | 31-45 | Hispanic/Latino | Cryopreserved | 1 mL | 10 | 10M | — | Atopic Dermatitis (Eczema) | United States | 2026 | A*01:01:01G/A*29:02:01G | B*44:03:01G/B*52:01:01G | C*04:01:01G/C*12:02:01G | — | — | — | — | — | — | PBMC | 10M cells | EDTA | Atopic Dermatitis (Eczema) | Atopic Dermatitis | No | 36.02 | Reactive | Yes | No | No | No | NO | No | Stored | In Stock |
$530 / vial
10 vials left
|
||||||||||||||
| Healthy PBMC | 82308 | 156355 | Male | 18-30 | Caucasian Hispanic/Latino Asian/Pacific Islander | Cryopreserved | 1 mL | 49 | 100M | — | — | United States | 2026 | 02:01:01G/24:02:01G | 44:02:01G | 05:01:01G | 04:02:01G/13:01:01G | 01:01:01G | 01:03:01G/03:01:01G | 03:02:01G/06:03:01G | 01:03:01G/02:01:01G | 04:01:01G/10:01:01G | PBMC | 100M cells | ACD | Normal (Healthy) | Healthy | No | 32.98 | Non Reactive | Yes | No | No | No | NO | Yes | B | RH+ | Stored | In Stock |
$578 / vial
49 vials left
|
||||||||||||
| Healthy PBMC | 82308 | 156355 | Male | 18-30 | Caucasian Hispanic/Latino Asian/Pacific Islander | Cryopreserved | 1 mL | 12 | 25M | — | — | United States | 2026 | 02:01:01G/24:02:01G | 44:02:01G | 05:01:01G | 04:02:01G/13:01:01G | 01:01:01G | 01:03:01G/03:01:01G | 03:02:01G/06:03:01G | 01:03:01G/02:01:01G | 04:01:01G/10:01:01G | PBMC | 25M cells | ACD | Normal (Healthy) | Healthy | No | 32.98 | Non Reactive | Yes | No | No | No | NO | Yes | B | RH+ | Stored | In Stock |
$248 / vial
12 vials left
|
||||||||||||
| Atopic Dermatitis (Eczema) Serum | 82520 | 138119 | Female | 31-45 | Hispanic/Latino | Frozen | 1 mL | 5 | — | — | Atopic Dermatitis (Eczema) | United States | 2026 | A*01:01:01G/A*29:02:01G | B*44:03:01G/B*52:01:01G | C*04:01:01G/C*12:02:01G | — | — | — | — | — | — | Serum | 1.0 ML | SST | Atopic Dermatitis (Eczema) | Atopic Dermatitis | No | 36.02 | Reactive | Yes | No | No | No | NO | No | Stored | In Stock |
$316 / vial
5 vials left
|
||||||||||||||
| Atopic Dermatitis (Eczema) Plasma | 82520 | 138119 | Female | 31-45 | Hispanic/Latino | Frozen | 1 mL | 16 | — | — | Atopic Dermatitis (Eczema) | United States | 2026 | A*01:01:01G/A*29:02:01G | B*44:03:01G/B*52:01:01G | C*04:01:01G/C*12:02:01G | — | — | — | — | — | — | Plasma | 1.0 ML | EDTA | Atopic Dermatitis (Eczema) | Atopic Dermatitis | No | 36.02 | Reactive | Yes | No | No | No | NO | No | Stored | In Stock |
$316 / vial
16 vials left
|
||||||||||||||
| Healthy Serum | 82498 | 134789 | Female | 46-60 | Caucasian African American Native American | Frozen | 1 mL | 3 | — | — | — | United States | 2026 | 03:01:01G/36:01:01G | 45:01:01G | 16:01:01G | 13:02:01G | — | 01:02:01G | 05:01:01G/06:09:01G | 01:03:01G/02:02:02G | 01:01:01G/04:01:01G | Serum | 1.0 ML | SST | Normal (Healthy) | Healthy | No | 25.33 | Reactive | Yes | Yes | No | Yes | NO | Yes | A | RH+ | Stored | In Stock |
$132 / vial
3 vials left
|
||||||||||||
| Healthy Serum | 82536 | 141047 | Male | 31-45 | Asian/Pacific Islander | Frozen | 1 mL | 2 | — | — | — | United States | 2026 | — | — | — | — | — | — | — | — | — | Serum | 1.0 ML | SST | Normal (Healthy) | Healthy | No | 22.15 | CMV Positive | Yes | Yes | No | No | NO | Yes | Stored | In Stock |
$132 / vial
2 vials left
|
Adding a lot to your cart does not reserve it. Lots are confirmed when the order is placed.
Vial counts can change between daily syncs; a ✓ shows when a lot's count was last checked, not a hold.
Showing 1–25 of 4,286 lots* Primary diagnosis is EHR-verified. Comorbidities are donor-reported; EHR-verified comorbidity data is available on request.